
Albunet is a working group of the European Society for Artificial Organs (ESAO) and is active as a cooperative research platform.
01
ABOUT
What is Albunet?
We are a group of experts from basic research and applied medical science, both from academia and industry, working together with the focus on the functionality of the albumin molecule in various diseases and related in vitro and clinical therapies, such as hemodialysis, albumin-dialysis in liver therapies and the use of this protein in apheresis-treatments.
02
BOARD MEMBERS
Who is Albunet?

Stefan Baudis
Vice President Global Affairs
CytoSorbents Europe
Albunet Finance

Gerd Klinkmann
Intensivist
University Hospital Rostock
Albunet President

Kristina Boss
Nephrologist
University Hospital Essen
Albunet Networking
03
PARTNER
Where is Albunet?

04
UPCOMING EVENTS
What is coming next?

05
ALBUNET SYMPOSIUM
50th ESAO Aachen | 9:15am Location K2
- BRIDGING THE KNOWLEDGE GAP BETWEEN SCIENTIFIC DISCOVERY AND CLINICAL APPLICATION: A CRUCIAL STEP FOR EFFECTIVE HEALTHCARE
Gerd Klinkmann, Rostock, Germany - INDOXYL SULFATE CLEARANCE RISES WITH TEMPERATURE: BUT IS THERE A HYSTERESIS EFFECT?
João Brás, Utrecht, the Netherlands - SELECTIVE REMOVAL OF GLYCATED AND OXIDIZED ALBUMIN BY ADSOPTION: MISSION IMPOSSIBLE?
Jens Hartmann, Krems, Austria - ALTERATIONS OF ALBUMIN FUNCTION AFTER KIDNEY TRANSPLANTATION
Kristna Boss, Essen, Germany - IMPACT OF HEMOADSORPTION ON LEVELS AND CHARACTERISTICS OF ALBUMIN – WHERE ARE WE?
Maria Taborda-Kuepper, CytoSorbents Europe GmbH, Germany